Investors are often guided by the idea of discovering 'the next big thing', even if that means buying 'story stocks' without any revenue, let alone profit. Unfortunately, these high risk investments ...

(Reuters) - U.S. lab products provider Avantor Inc will buy Masterflex from privately held Antylia Scientific in a $2.9 billion all-cash deal to beef up its COVID-19 therapy and vaccine manufacturing ...

For those who don't know, ROCE is a measure of a company's yearly pre-tax profit (its return), relative to the capital employed in the business. To calculate this metric for Masterflex, this is the ...

Antylia, a portfolio company of GTCR, has agreed to sell its Masterflex business unit to Avantor for $2.9 billion in all cash. The Masterflex arm is used by pharma and biotech customers for research ...

Masterflex SE (ETR:MZX) last week reported its latest half-yearly results, which makes it a good time for investors to dive in and see if the business is performing in line with expectations. It was a ...

Portfolio now includes standard, configurable, and engineered-to-order peristaltic pumps, single-use assemblies, and systems for R&D through high-volume manufacturing Designed for secure fluid ...

Following the acquisition, Avantor will have access to Masterflex’s various bioproduction operations. Avantor announced on Nov. 1, 2021, that it had completed a previously announced acquisition of the ...

U.S. lab products provider Avantor Inc will buy Masterflex from privately held Antylia Scientific in a $2.9 billion all-cash deal to beef up its COVID-19 therapy and vaccine manufacturing operations.

Avantor, Inc. AVTR recently announced a strategic expansion of its Masterflex brand across its fluid handling portfolio. The expansion integrates standard, configurable and engineered-to-order ...

RADNOR, Pa., Nov. 1, 2021 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technologies & ...